Related Experiment Video

Updated: Jun 9, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Recent advances in histone deacetylase targeted cancer therapy

Isamu Hoshino1, Hisahiro Matsubara

  • 1Department of Frontier Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.

Surgery Today
|August 27, 2010
PubMed

Insights

Histone deacetylase inhibitors (HDACIs) offer a promising new avenue for cancer therapy by targeting histone deacetylases (HDACs). This review explores recent advancements in HDACIs and their role in cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are key epigenetic regulators of gene expression.
  • HDACs are frequently implicated in cancer development and progression, making them attractive therapeutic targets.
  • Histone deacetylase inhibitors (HDACIs) modulate gene expression by altering the balance between histone deacetylation and acetylation.

Purpose of the Study:

  • To review recent developments in histone deacetylase inhibitors (HDACIs).
  • To explore various aspects of histone deacetylase (HDAC)-targeted cancer treatment.
  • To elucidate the mechanisms underlying the anticancer effects of HDACIs.

Main Methods:

  • Literature review of recent studies on HDACIs and HDAC-targeted cancer therapy.
  • Analysis of current clinical trials involving HDACIs.
  • Examination of the molecular mechanisms of HDAC inhibition in cancer.

Main Results:

  • Numerous HDACIs have been identified, with some progressing to clinical trials.
  • HDACIs demonstrate potential in cancer treatment by modulating gene expression.
  • The precise mechanisms of HDACIs' anticancer effects are still under investigation.

Conclusions:

  • HDACIs represent a significant advancement in cancer therapy.
  • Further research is needed to fully understand and optimize HDAC-targeted treatments.
  • HDAC-targeted cancer therapy holds considerable promise for future clinical applications.

More Related Videos

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue09:43

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue

Published on: November 30, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...